Abstract. This paper presents novel results of experiments focused on actin cytoskeleton organisation in pseudopodial structures of foraminifera. The main aim of this research was to test the hypotheses proposed to explain the previously reported granular pattern of F-actin labelling in several species of foraminifera with SiR-actin fluorescent probe. These hypotheses include the possibility that SiR-actin enhances the F-actin polymerisation or that it binds to other than F-actin compounds within foraminiferal cells, resulting in capturing the staining artefacts. The series of replicated experiments conducted on small miliolid Quinqueloculina sp. included double staining of F-actin with SiR-actin and phalloidin-based probes, complemented with observations of reticulopodia under the polarised light to identify the granules showing birefringence. All of performed experiments demonstrate highly congruent results expressed in SiR-actin and phalloidin co-labelling patterns, especially pronounced with the small granular objects (SiR-actin labelled granules or ALGs). Furthermore, the birefringence strongly tends to characterise primarily areas stained with both of the probes. These results rule out staining artefacts and support existence of actin cytoskeleton associated with micrometre-size motile granules. We discuss possible implications of this granular pattern that facilitates efficient formation and fast reorganization of extended granuloreticulopodia and other pseudopodial structures. If this is the case, they are one of the key evolutionary adaptations of these organisms that most likely predates the evolution of the foraminiferal tests that started in the early Palaeozoic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.